Ragosa Mark bought KNSA
March 9, 2026 · Form 4 insider transaction
Ragosa Mark bought 10,360 shares of Kiniksa Pharmaceuticals International, plc at $26.74 per share, a transaction worth $277.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,360
Price
$26.74
Total value
$277.0K
InsiderRagosa Mark
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeM: Option exercise
Transaction dateMarch 9, 2026
Filing dateMarch 11, 2026
Shares owned after48,808
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on August 14, 2025.